Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 14q12 Microdeletion Syndrome C4305240
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 14q12 Microdeletion Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
14q12 Microdeletion Syndrome C4305240
A rare chromosomal condition where a segment of chromosome 14 is missing. It may cause developmental delays and other health concerns. Treatment is supportive and individualized.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
14q12 Microdeletion Syndrome C4305240
0-1
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
14q12 Microdeletion Syndrome C4305240
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
14q12 Microdeletion Syndrome C4305240
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
14q12 Microdeletion Syndrome C4305240
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
14q12 Microdeletion Syndrome C4305240
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
14q12 Microdeletion Syndrome C4305240
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 14q12-microdeletion-syndrome-C4305240 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 14q12 Microdeletion Syndrome C4305240 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as possible, within a severe congenital presentation. | Described as possible, with generally moderate severity. | Low |
| Intellectual disability | May occur according to the supplied description. | Not specifically established in the supplied description. | Moderate |
| Distinctive facial features | May be present, but exact features are not specified. | Not established from the supplied source. | Moderate |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
Chromosomal testing identifies the specified chromosome 21 region deletion.
The diagnosis depends on the deleted locus, not symptoms alone.
High
Severe congenital developmental disability is documented.
This matches the supplied severity label, but is not diagnostic by itself.
Low
Intellectual disability and facial differences are both reported.
These are mentioned for the left condition, though details are sparse.
Low
Choose 14q12 Microdeletion Syndrome C4305240 when
Testing confirms a microdeletion at 14q12.
Locus confirmation distinguishes it from a chromosome 21 deletion.
High
Developmental delay occurs with moderate overall severity.
This aligns with the supplied severity, without proving the diagnosis.
Low
Support needs are individualized without a specified facial pattern.
The source gives only broad developmental and health concerns.
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 14q12 Microdeletion Syndrome C4305240 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect deletion involving the stated chromosome 21 region. | May detect deletion at 14q12. | The genomic locus, not clinical severity, establishes the distinction. |
| Developmental assessment | May show delay; intellectual disability is possible. | May show developmental delay of variable degree. | Assessments guide support but cannot identify the chromosome involved. |
| Clinical genetics evaluation | May note congenital features, including possible facial differences. | May identify associated health concerns not specified here. | Findings require correlation with genetic results and clinician review. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- A chronic congenital course is indicated; exact outcomes are not established.
- Factors
- Supplied severity is severe, with possible developmental and intellectual disability.
14q12 Microdeletion Syndrome C4305240
- Outcome
- A chronic course with moderate severity is indicated; exact outcomes are unknown.
- Factors
- Developmental delay and unspecified health concerns may influence needs.
Time frame: From early life onward; precise onset and long-term course are not established.
Deleted locus, individual development, associated medical findings, and access to support.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Possible and potentially severe. Possible, with moderate severity suggested. Degree varies; no outcome rates are established in the source. |
| Associated medical problems | Monitoring is advised, but specific complications are not listed. Other health concerns may occur but are unspecified. Do not infer organ-specific complications without clinical evidence. |
| Support needs | Developmental support and medical monitoring are emphasized. Supportive, individualized treatment is described. Needs should be reassessed over time by the care team. |
Patient education highlights
- HighGenetic confirmation
Symptoms overlap; chromosomal testing and clinician interpretation determine which condition applies.
- HighSupportive care
Management focuses on developmental support, monitoring, and individualized services rather than a single disease-specific cure.
- MediumUncertainty
The supplied data do not establish exact features, prevalence, life expectancy, or treatment doses.